Samuel K Peasah1, Niccie L McKay1, Jeffrey S Harman2, Mona Al-Amin3, Robert L Cook4. 1. Mercer University-College of Pharmacy. 2. University of Florida-Department of Health Services Research, Management, and Policy. 3. Suffolk University-Sawyer Business School. 4. University of Florida-Department of Epidemiology.
Abstract
BACKGROUND: Medicare ceased payment for some hospital-acquired infections beginning October 1, 2008, following provisions in the Medicare Modernization Act of 2003 and the Deficit Reduction Act of 2005. OBJECTIVE: We examined the association of this policy with declines in rates of vascular catheter-associated infections (VCAI) and catheter-associated urinary tract infection (CAUTI). DATA: Discharge data from the Florida Agency for Healthcare Administration from 2007 to 2011. STUDY DESIGN: We compared rates of hospital-acquired vascular catheter-associated infections (HA-VCAI) and catheter-associated urinary tract infections (HA-CAUTI) before and after implementation of the new policy (January 2007 to September 2008 vs. October 2008 to September 2011). This pre-post, retrospective, interrupted time series study was further analyzed with a generalized hierarchical logistic regression, by estimating the probability of a patient acquiring these infections in the hospital, post-policy compared to pre-policy. PRINCIPAL FINDINGS: Pre-policy, 0.12% of admitted patients were diagnosed with CAUTI; of these, 32% were HA-CAUTI. Similarly, 0.24% of admissions were diagnosed as VCAI; of these, 60% were HA-VCAI. Post-policy, 0.16% of admissions were CAUTIs; of these, 31% were HA-CAUTI. Similarly, 0.3% of admissions were VCAIs and, of these, 45% were HA-VCAI. There was a statistically significant decrease in HA-VCAIs (OR: 0.571 (p < 0.0001)) post-policy, but the reduction in HA-CAUTI (OR: 0.968 (p < 0.4484)) was not statistically significant. CONCLUSIONS: The results suggest Medicare non payment policy is associated with both a decline in the rate of hospital-acquired VCAI (HA-VCAI) per quarter, and the probability of acquiring HA-VCAI post- policy. The strength of the association could be overestimated, because of concurrent ongoing infection control interventions.
BACKGROUND: Medicare ceased payment for some hospital-acquired infections beginning October 1, 2008, following provisions in the Medicare Modernization Act of 2003 and the Deficit Reduction Act of 2005. OBJECTIVE: We examined the association of this policy with declines in rates of vascular catheter-associated infections (VCAI) and catheter-associated urinary tract infection (CAUTI). DATA: Discharge data from the Florida Agency for Healthcare Administration from 2007 to 2011. STUDY DESIGN: We compared rates of hospital-acquired vascular catheter-associated infections (HA-VCAI) and catheter-associated urinary tract infections (HA-CAUTI) before and after implementation of the new policy (January 2007 to September 2008 vs. October 2008 to September 2011). This pre-post, retrospective, interrupted time series study was further analyzed with a generalized hierarchical logistic regression, by estimating the probability of a patient acquiring these infections in the hospital, post-policy compared to pre-policy. PRINCIPAL FINDINGS: Pre-policy, 0.12% of admitted patients were diagnosed with CAUTI; of these, 32% were HA-CAUTI. Similarly, 0.24% of admissions were diagnosed as VCAI; of these, 60% were HA-VCAI. Post-policy, 0.16% of admissions were CAUTIs; of these, 31% were HA-CAUTI. Similarly, 0.3% of admissions were VCAIs and, of these, 45% were HA-VCAI. There was a statistically significant decrease in HA-VCAIs (OR: 0.571 (p < 0.0001)) post-policy, but the reduction in HA-CAUTI (OR: 0.968 (p < 0.4484)) was not statistically significant. CONCLUSIONS: The results suggest Medicare non payment policy is associated with both a decline in the rate of hospital-acquired VCAI (HA-VCAI) per quarter, and the probability of acquiring HA-VCAI post- policy. The strength of the association could be overestimated, because of concurrent ongoing infection control interventions.
Authors: Gary J Young; Bert White; James F Burgess; Dan Berlowitz; Mark Meterko; Matthew R Guldin; Barbara G Bokhour Journal: Am J Med Qual Date: 2005 May-Jun Impact factor: 1.852
Authors: Laura A Petersen; LeChauncy D Woodard; Tracy Urech; Christina Daw; Supicha Sookanan Journal: Ann Intern Med Date: 2006-08-15 Impact factor: 25.391
Authors: Peter Pronovost; Dale Needham; Sean Berenholtz; David Sinopoli; Haitao Chu; Sara Cosgrove; Bryan Sexton; Robert Hyzy; Robert Welsh; Gary Roth; Joseph Bander; John Kepros; Christine Goeschel Journal: N Engl J Med Date: 2006-12-28 Impact factor: 91.245
Authors: Grace M Lee; Ken Kleinman; Stephen B Soumerai; Alison Tse; David Cole; Scott K Fridkin; Teresa Horan; Richard Platt; Charlene Gay; William Kassler; Donald A Goldmann; John Jernigan; Ashish K Jha Journal: N Engl J Med Date: 2012-10-11 Impact factor: 91.245
Authors: M Todd Greene; Robert Chang; Latoya Kuhn; Mary A M Rogers; Carol E Chenoweth; Emily Shuman; Sanjay Saint Journal: Infect Control Hosp Epidemiol Date: 2012-08-23 Impact factor: 3.254
Authors: Jennifer A Meddings; Heidi Reichert; Mary A M Rogers; Sanjay Saint; Joe Stephansky; Laurence F McMahon Journal: Ann Intern Med Date: 2012-09-04 Impact factor: 25.391
Authors: Dane K Wukich; Jeffrey W Dikis; Spencer J Monaco; Kristin Strannigan; Natalie C Suder; Bedda L Rosario Journal: Foot Ankle Int Date: 2015-05-12 Impact factor: 2.827
Authors: Derek K Juang; Scott T Johns; Dipesh Solanky; Ian C Drobish; Sanjay R Mehta; Monika Kumaraswamy Journal: Infect Control Hosp Epidemiol Date: 2020-09-18 Impact factor: 6.520
Authors: Angela Ahlquist Cleveland; Lee H Harrison; Monica M Farley; Rosemary Hollick; Betsy Stein; Tom M Chiller; Shawn R Lockhart; Benjamin J Park Journal: PLoS One Date: 2015-03-30 Impact factor: 3.240